Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.InPedILD trial enrols first patient to evaluate nintedanib in pediatric population with fibrosing ILD
Boehringer Ingelheim enrols first patient in InPedILD trial. (Credit: Madras150/Wikimedia Commons)
Boehringer Ingelheim enrols first patient in InPedILD trial. (Credit: Madras150/Wikimedia Commons)